SABA inhaler carbon emissions drop by one-third
NHS England data has shown that average emissions for short-acting beta-2 agonist (SABA) inhalers prescribed in primary care declined by 33% between 2020 and November 2024 — from 24.2 kgCO2e to 16.1 kgCO2e. The Pharmaceutical Journal reports that this fall in SABA inhaler emissions most likely owes to patients switching from the Ventolin Evohaler to the Salamol inhaler.
NICE has produced a decision aid on asthma inhalers and climate change. It explains the options for patients thinking about reducing the carbon footprint of their asthma treatment and the options available.
Related Posts
Guidance for GPs in England on getting your pension record up to date
“One of the biggest challenges that GPs in England face is out of date and inaccurate pension records, with “missing…
Cut spending on Public Health
Obesity in the UK is a hot topic right now with two thirds of the adult population overweight or obese*. Not…
Repeat Prescribing Toolkit
This resource was commissioned by NHS England to address recommendation 7 of the National Overprescribing Review, which tasked the Royal Pharmaceutical…